Login / Signup
Initial combination of metformin, sitagliptin, and empagliflozin in drug-naïve patients with type 2 diabetes: Safety and metabolic effects.
Soo Lim
Minji Sohn
Yujin Shin
Eleuterio Ferrannini
Published in:
Diabetes, obesity & metabolism (2022)
Keyphrases
</>
emergency department
adverse drug
drug induced